Max Robotics — Global Service Robot Directory + US Certification

About

Lukas Bubendorf is a leading urologic oncologist whose research focuses on improving the precision of prostate cancer diagnosis and treatment through advanced imaging and robotic technologies. His work centers on refining MRI-targeted biopsy techniques and optimizing surgical outcomes in robot-assisted radical prostatectomy. In a landmark 2021 study (17 citations), Bubendorf demonstrated that while MRI-US fusion targeted saturation biopsy significantly improves detection of clinically significant prostate cancer, intralesional tumor heterogeneity remains a critical challenge—up to 70% of lesions display this variability, which current sampling strategies fail to address adequately. His prospective study of 118 patients provided crucial insights for developing more comprehensive biopsy protocols. More recently, in 2024, Bubendorf pioneered the use of personalized 3D-printed prostate models derived from pelvic MRI to guide secondary resection of positive surgical margins during nerve-sparing robot-assisted radical prostatectomy. This innovative approach enhances surgical precision when frozen section analysis detects residual cancer, potentially improving oncologic outcomes while preserving erectile function. His work bridges the gap between diagnostic imaging and surgical intervention, advancing personalized treatment strategies for prostate cancer patients.